Human Genome Epidemiology Literature Finder
|
Records 1 - 8 (of 8 Records) |
| Query Trace: Thrombosis and CYP4F2[original query] |
|---|
A genome-wide association study confirms VKORC1, CYP2C9, and CYP4F2 as principal genetic determinants of warfarin dose.
PLoS genetics 2009 Mar 5 (3): e1000433. Takeuchi Fumihiko, McGinnis Ralph, Bourgeois Stephane, Barnes Chris, Eriksson Niclas, Soranzo Nicole, Whittaker Pamela, Ranganath Venkatesh, Kumanduri Vasudev, McLaren William, Holm Lennart, Lindh Jonatan, Rane Anders, Wadelius Mia, Deloukas Pan |
| A regression model to predict warfarin dose from clinical variables and polymorphisms in CYP2C9, CYP4F2, and VKORC1: Derivation in a sample with predominantly a history of venous thromboembolism. Thrombosis research 2010 Jun 125 (6): e259-64. Wells P S, Majeed H, Kassem S, Langlois N, Gin B, Clermont J, Taljaard |
| Warfarin pharmacogenetics: development of a dosing algorithm for Omani patients. Journal of human genetics 2012 Oct 57 (10): 665-9. Pathare Anil, Al Khabori Murtadha, Alkindi Salam, Al Zadjali Shoaib, Misquith Rhea, Khan Hammad, Lapoumeroulie Claudine, Paldi Andras, Krishnamoorthy Rajagop |
| Effect of clinical factors and gene polymorphism of CYP2C19*2, *17 and CYP4F2*3 on early stent thrombosis. Pharmacogenomics 2015 16 (3): 181-9. Kupstyte Nora, Zaliunas Remigijus, Tatarunas Vacis, Skipskis Vilius, Zaliaduonyte-Peksiene Diana, Grabauskyte Ingrida, Dovidaitiene Dovile, Bumblauskas Karolis, Gustiene Olivija, Lesauskaite Vai |
| Plasma levels of vitamin K and the risk of ischemic heart disease: a Mendelian randomization study. Journal of thrombosis and haemostasis : JTH 2016 Apr . Schooling C Ma |
| Impact of genetic and clinical factors on warfarin therapy in patients early after heart valve replacement surgery. European journal of clinical pharmacology 2019 8 75 (12): 1685-1693. Li Boxia, Liu Ruisheng, Wang Chengqi, Ren Changan, Zhang Shiming, Zhang Fan, Zhang Jianping, Liu Shidong, Wei Yuhui, Liu Wenjing, Song Bing, Wu Xin |
| Prosthetic valve thrombosis - association of genetic polymorphisms of VKORC1, CYP2C9 and CYP4F2 genes. Medicine 2019 Feb 98 (6): e14365. Sr Kalpana, G Bharath, Jain Simran, Moorthy Nagaraja, Manjunath Satvic C, Christopher Ri |
| Genetic Polymorphism Effect on Warfarin-Rifampin Interaction: A Case Report and Review of Literature. Pharmacogenomics and personalized medicine 2021 2 14 149-156. Salem Muhammad, Eljilany Islam, El-Bardissy Ahmed, Elewa Haz |
- Page last reviewed:Feb 1, 2024
- Content source: